About 1 result found for searched term "Lorlatinib (PF-06463922)" (0.128 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3975 | Lorlatinib (PF-06463922) | ALK |
| PF-06463922 | ||
| Lorlatinib (PF-06463922) is an oral active, selective, brain osmotic and ATP-competitive ROS1/ALK inhibitor. The Ki of Lorlatinib for ROS1, wild-type ALK and ALK(L1196M) were <0.025 nM, <0.07 nM and 0.7 nM, respectively. Lorlatinib has anticancer activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
